fda changes semaglutide Semaglutide: The Drug of Today and a Steppingstone to Tomorrow Why you will no longer

Who Qualifies for Weight Loss Medications Prescription weight loss medications are suitable for adults with a BMI of 30 or higher, or of 27 with an associated health condition like diabetes or high blood pressure

Semaglutide and Tirzepatide Semaglutide is primarily a GLP-1 receptor agonist Tirzepatide targets GLP-1 and GIP receptors Retatrutide targets GLP-1, GIP, and glucagon receptor pathways Because retatrutide activates additional metabolic receptors, some studies suggest that retatrutide may deliver greater weight loss compared with semaglutide and tirzepatide

The option to use pre-tax dollars from HSA/FSA accounts to purchase semaglutide considerably alleviates this financial barrier

What We Can Offer Virtual consultations with diabetes care specialists

Expect monthly contact with your physician during titration